Evidence map›Paper›PMID 35813244›Full record

ArticleMatrix biology plus2022

Metabolic systems analysis identifies a novel mechanism contributing to shock in patients with endotheliopathy of trauma (EoT) involving thromboxane A2 and LTC

Hanne H Henriksen, Igor Marín de Mas, Helena Herand, Joseph Krocker, Charles E Wade, Pär I Johansson

Open access · goldAbstract read
In one paragraph

Article in Matrix biology plus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The glycocalyx: Pathobiology and repair.Matrix biology plus · 2023
    Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Hanne H HenriksenDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Igor Marín de MasCAG Center for Endotheliomics, Copenhagen University Hospital, Rigshospitalet, Denmark.
Helena HerandCAG Center for Endotheliomics, Copenhagen University Hospital, Rigshospitalet, Denmark.
Joseph KrockerCenter for Translational Injury Research, Department of Surgery, University of Texas Health Science Center, Houston, TX, USA.
Charles E WadeCenter for Translational Injury Research, Department of Surgery, University of Texas Health Science Center, Houston, TX, USA.
Pär I JohanssonDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Novo Nordisk Foundation · DKThe University of Texas Health Science Center at Houston · USCopenhagen University Hospital · DKRigshospitalet · DK

Funding

ROLE OF THE GUT IN POST INJURY MULTIPLE ORGAN FAILURET32GM008792 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Charles S Cox · 2001 to 2026
$5.2M
NIGMS NIH HHS T32 GM008792
6 · The paper itself

Abstract

Purpose: Endotheliopathy of trauma (EoT), as defined by circulating levels of syndecan-1 ≥ 40 ng/mL, has been reported to be associated with significantly increased transfusion requirements and a doubled 30-day mortality. Increased shedding of the glycocalyx points toward the endothelial cell membrane composition as important for the clinical outcome being the rationale for this study. Results: The plasma metabolome of 95 severely injured trauma patients was investigated by mass spectrometry, and patients with EoT vs. non-EoT were compared by partial least square-discriminant analysis, identifying succinic acid as the top metabolite to differentiate EoT and non-EoT patients (VIP score = 3). EoT and non-EoT patients' metabolic flux profile was inferred by integrating the corresponding plasma metabolome data into a genome-scale metabolic network reconstruction analysis and performing a functional study of the metabolic capabilities of each group. Model predictions showed a decrease in cholesterol metabolism secondary to impaired mevalonate synthesis in EoT compared to non-EoT patients. Intracellular task analysis indicated decreased synthesis of thromboxanA2 and leukotrienes, as well as a lower carnitine palmitoyltransferase I activity in EoT compared to non-EoT patients. Sensitivity analysis also showed a significantly high dependence of eicosanoid-associated metabolic tasks on alpha-linolenic acid as unique to EoT patients. Conclusions: Model-driven analysis of the endothelial cells' metabolism identified potential novel targets as impaired thromboxane A2 and leukotriene synthesis in EoT patients when compared to non-EoT patients. Reduced thromboxane A2 and leukotriene availability in the microvasculature impairs vasoconstriction ability and may thus contribute to shock in EoT patients. These findings are supported by extensive scientific literature; however, further investigations are required on these findings.

Indexed as

AA, Arachidonic acidCPT1, Carnitine palmitoyltransferase IEC, Endothelial cellEC-GEM, Genome-scale metabolic model of the microvascular endothelial cellEicosanoidELISA, Enzyme-linked immunosorbent assayEndotheliopathyEoT, Endotheliopathy of traumaFBA, Flux balance analysisGEMs, Genome-scale metabolic modelsGenome-scale metabolic modelHMG-CoA, Hydroxymethylglutaryl-CoAISS, Injury Severity ScoreLTC4, Leukotriene C4MetabolomicsPCA, Principal Component AnalysisPLS-DA, Partial least square-discriminant analysisSystems biologyTrauma

Identifiers

PMID35813244
PMCPMC9260291
OpenAlexW4283122949

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.